TRAITEMENT CONTRE LE CANCER PHARMACORÉSISTANT PAR ADMINISTRATION D'UN CONJUGUÉ ANTICORPS ANTI-HER2/MÉDICAMENT

• 收藏
• 分享

专利权人:

Limited;Daiichi Sankyo Company

发明人:

JIKOH Takahiro,OGITANI Yusuke,YOSHIHARA Kazutaka,ENDO Seiko,FUJISAKI Yoshihiko

申请号：

EP17858462

公开号：

EP3524267A4

申请日:

2017.10.05

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

As treatment effective for HER2-expressing cancer having resistance or refractoriness to an existing anti-HER2 drug, there are provided a therapeutic agent and a treatment method using an antibody-drug conjugate in which a linker and a drug represented by the formula: - (Succinimid-3-yl-N)-CHCHCHCHCH-C(=O)-GGFG-NH-CH-O-CH-C(=O)-(NH-DX) are conjugated to an anti-HER2 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/